Graphite Bio Inc.
GRPH,
+22.24%
received a warm reception on Wall Street, as the California-based gene-editing biotechnology company’s stock opened 30% above its initial public offering price. The IPO priced overnight at $17 a share, at the top of the…

Click here to view the original article.